Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules
Condition(s):Healthy Volunteers; Bioequivalence StudyLast Updated:September 7, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Healthy Volunteers; Bioequivalence StudyLast Updated:September 7, 2022Completed
Condition(s):Healthy Volunteers; Bioequivalence StudyLast Updated:September 7, 2022Completed
Condition(s):Bioequivalence StudyLast Updated:February 10, 2017Completed
Condition(s):Healthy; PharmacokinteticsLast Updated:September 7, 2022Completed
Condition(s):Bioequivalence StudyLast Updated:September 28, 2023Not yet recruiting
Condition(s):Bioequivalence StudyLast Updated:February 22, 2024Not yet recruiting
Condition(s):Bioequivalence StudyLast Updated:April 3, 2023Recruiting
Condition(s):HealthyLast Updated:April 29, 2022Completed
Condition(s):HealthyLast Updated:February 10, 2017Completed
Condition(s):Bioequivalence StudyLast Updated:January 18, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.